METTL3 plays a key role in replicating senescence of colorectal cancer (CRC) cells, and inhibition of METTL3 or targeted inhibition of CDKN2B methylation can effectively inhibit CRC senescence (Chen et al., 2024). Here, METTL3 is linked to colorectal cancer.